Our research underscores the transformative potential of integrating GLP-1 receptor agonist medications with intensive lifestyle interventions (ILI) in a virtual setting
Impaired adipogenesis and dysfunctional adipose tissue in human hypertrophic obesity
To optimize KAI-7535s overall clinical profile for the treatment of obesity in diverse patient populations, we are assessing a wide dose range, a lower starting dose, and a more gradual titration in our ongoing Phase 2 global clinical trial, Kailera Chief Medical Officer Scott Wasserman said in a prepared statement
Dietary Supplementation with Glycine Enhances Intestinal Mucosal Integrity and Ameliorates Inflammation in C57BL/6J Mice with High-Fat Diet-Induced Obesity Perricone C., et al
Liposomal delivery uses healthy fats to protect the molecule and support absorption at the cellular level
Epidemiological evidence has increasingly suggested that metformin, a commonly prescribed medication for type 2 diabetes, protects against the development of neurodegenerative diseases [23]